Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSP3-LSP Vaccine Phase IIb in Malian Children
NCT00652275Phase 2Unknown
- Sponsor
- African Malaria Network Trust
- Start
- May 2008
- Primary completion
- Nov 2010
- Modality
- Modified Peptides, Vaccines & Immunotherapeutics, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of merozoite surface protein 3 long synthetic peptide in malaria, sponsored by African Malaria Network Trust. Status: unknown.
02
Drugs
merozoite surface protein 3 long synthetic peptide
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00652275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00652275.